drugset / Trial / NCT02095145
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance
RandomizedParallel-groupDouble-blindPrevention
Summary
This randomized phase II trial studies pomegranate-extract pill in preventing tumor growth in patients with prostate cancer that is limited to a certain part of the body (localized), who have chosen observation as their treatment plan. The use of pomegranate-extract pill may slow disease progression in patients with localized prostate cancer.
Timeline
- Start
- 2014-05-08
- Primary completion
- 2018-01-23
- Completion
- 2019-09-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pomegranate fruit extract | Unknown | 1000 mg | Oral |